U.S. v. Ruttenberg

• Decision Date: 09 July 1980
• Docket Number: Nos. 79-2440,79-2449,s. 79-2440
• Citation: 625 F.2d 173
• Parties: UNITED STATES of America, Plaintiff-Appellee, v. Norman RUTTENBERG, et al., Defendants-Appellants. UNITED STATES of America, Plaintiff-Appellee, v. ROYAL FONTANA NURSING CENTER, INC., Defendant-Appellant.
• Court: U.S. Court of Appeals — Seventh Circuit

Page 173

625 F.2d 173

UNITED STATES of America, Plaintiff-Appellee, v. Norman RUTTENBERG, et al., Defendants-Appellants.

UNITED STATES of America, Plaintiff-Appellee, v. ROYAL FONTANA NURSING CENTER, INC., Defendant-Appellant.

Nos. 79-2440, 79-2449.

United States Court of Appeals, Seventh Circuit.

Argued April 29, 1980.

Decided July 9, 1980.

Alan O. Amos, Collins & Amos, Marilee Roberg, Pedersen & Houpt, Chicago, Ill., for defendants-appellants.

Thomas P. Sullivan, U. S. Atty., Michael Siegel, Asst. U. S. Atty., Chicago, Ill., for plaintiff-appellee.

Before WOOD, Circuit Judge, MARKEY, Chief Judge, ^* and CUDAHY, Circuit Judge.

MARKEY, Chief Judge.

Norman Ruttenberg, Dan Lipman, Hyman Naiman, Sam Weintraub, Emanuel Ray, Theodore Dolitsky and Royal Fontana Nursing Center, Inc. appeal the denial by the United States District Court for the Northern District of Illinois of a Writ of Error Coram Nobis vacating their earlier sentences and remitting their fines with statutory interest. We affirm.

Background

In 1976 appellants were charged with violations of 18 U.S.C. § 1341 (1972) ¹ and 42 U.S.C. § 1396h(b)(1) (1972) (amended 1977). ² The indictments of the individual appellants alleged in summary that Dolitsky provided drugs and other pharmaceutical supplies to nursing homes owned by the individual defendants, that Dolitsky paid monthly "fees" to the defendants "for the opportunity to provide drugs and pharmaceutical services," that the fees were paid through "Multicare Management Co." (MMC), were described as "fees for consulting services," and were distributed by MMC to the nursing home owners in amounts totalling over $42,000.

The information filed against Royal Fontana Nursing Center charged it with soliciting and receiving bribes and kickbacks from Glick Drug Company in connection with Glick's furnishing of drugs and pharmaceutical services.

In late 1976 and early 1977 appellants plead guilty and were sentenced to terms of imprisonment or probation and fined substantial sums. The sentences have been served, the periods of probation have expired, and the fines have been paid.

In May and June of 1979 appellants filed motions in the District Court, under 28 U.S.C. § 1651(a) (1976), ³ for Writs of Error Coram Nobis, based on assertions that the indictments failed to state an offense cognizable under either 18 U.S.C. § 1341 or 42 U.S.C. § 1396h(b)(1). Appellants relied on United States v. Zacher, ⁴ 586 F.2d 912 (2d Cir. 1978) and United States v. Porter, ⁵ 591 F.2d 1048 (5th Cir. 1979). On September 27, 1979, District Judge John Powers Crowley denied the Royal Fontana motion, and on November 13, 1979, District Judge Frank J. McGarr denied the Ruttenberg, et al. motion.

Issue

The dispositive issue is whether the indictments and information filed against appellants failed to charge a crime under the applicable statutes.

OPINION

Having plead guilty, appellants have admitted the allegations in the indictments and information and have waived all non-jurisdictional defects therein other than sufficiency. United States v. Michigan Carton Co., 552 F.2d 198, 202 (7th Cir. 1977). Thus the issue here is solely whether the indictments and information sufficiently allege the crimes of offering and receiving a kickback under § 1396h(b)(1). United States v. Hancock, 604 F.2d 999, 1001 (7th Cir. 1979).

Appellants say, "In both Zacher and Porter, the government paid only the amounts it had fixed for the services or supplies provided, no false bills were submitted, no public officials were bribed or otherwise involved, and no statute or regulation required the doctors or nursing home owners to deal with different laboratories or pharmacies or to use different services or supplies than they did," and that the same is true here. In so saying, appellants misconstrue their position. Nothing in the present indictments and information, or in the statute, refers in any manner to governmentally fixed prices, or false bills, or public officials, or requirements for dealing with multiple suppliers, nor are any of those elements established as facts on the record. ⁶ A defendant who has plead guilty may not "transcend the four-corners of the indictment in order to demonstrate its insufficiency." United States v. Di Fonzo, 603 F.2d 1260, 1263 (7th Cir. 1979).

Thus it cannot be contested that the indictments and information sufficiently alleged kickbacks. The indictments state that Dolitsky "would and did pay a monthly kickback or bribe to (MMC) for the opportunity to provide drugs and pharmaceutical services to patients at (several nursing homes owned by appellants) . . ." and that MMC distributed the sums paid to those nursing homes, the payments being disguised as debts owed by MMC. The information charged "Royal Fontana Nursing Center, Inc. . . . did solicit and receive a kickback and bribe from Glick Drug Company in the amount of $3.00 per month for each public aid patient. . . ." Appellants' arguments reduce to an assertion that their admitted actions did not constitute a kickback under the statute. For that purpose, defendants compare their actions with the definition of "kickback" set forth in Porter : "the secret return to an earlier possessor of part of a sum received." 591 F.2d at 1054 (emphasis in original). ⁷

Whatever may be said of that definition, or of the ratio decidendi in Zacher and Porter, the decision and opinion of this court in Hancock is controlling in this case. In Hancock the defendants plead guilty to one count of an indictment charging violation of 42 U.S.C. §§ 1395nn(b)(1) ⁸ and 1396h(b) (1) (1972) (amended 1977). Defendants had been paid what they called "handling fees" for referring blood and tissue specimens to the fee-paying laboratory. This court distinguished Zacher, where non-corrupt payments were found, saying "In the present case, however, the indictments do allege corrupt payments which were admitted by defendants' pleas." The Porter definition of "kickback" was rejected by this court, which adopted as its definition: " 'a percentage payment . . . for granting assistance by one in a position to open up or control a source of income,' Webster's Third New International Dictionary (1966)," 604 F.2d at 1002. An argument that § 1396h(b)(1) was unconstitutionally vague was rejected, because the statute gives fair notice that defendants' conduct was illegal. Id. Viewing the term "kickback" as a commonly understood term encompassing payment for a corrupt purpose, this court held that § 1396h(b)(1) did not omit intent as an element of the crime. To the extent that Porter reflected views in conflict with those in Hancock, this court expressly declined to adopt the former. Id.

Appellants say Hancock is not controlling because the fee agreement in Hancock raised costs to the Medicare system, whereas the government's election to fix the price of drugs and pharmaceuticals precludes that result here. Though the argument, albeit outside the four corners of the indictment/information, may be considered as related to an interpretation of kickback, it does not aid appellants. The government disputes the existence of increased costs in Hancock, where, as here, no increased costs were alleged. Appellants rely on this statement by the court in Hancock : "(T)he element of corruption is found in this allegation that the defendants received payments in return for their decision to send specimens to Chem-Tech. The potential for increased costs to the Medicare-Medicaid system is plain, where payments for the exercise of such judgments are added to the legitimate costs of the transaction." United States v. Hancock, 604 F.2d at 1001. Whether costs were directly and immediately increased by those particular payments, however, is irrelevant. The potential for increased costs if such "fee" agreements become an established and accepted method of business is clearly an evil with which the court was concerned and one Congress sought to avoid in enacting § 1396h(b) (1). Id.

We think the term "kickback," though apparently originating in the vernacular, was fully understood by the public and the Congress, when the statute was enacted, to mean the transfer back to one having control of the original payment, and that a resulting increase in total cost to the government was not only known to be less common but considered irrelevant. ⁹

In arguing that the payments here were not of "federal funds" but merely gifts by a grateful Dolitsky from his profits, the individual appellants misread the statute, which describes only the payment to Dolitsky as "out of Federal funds." Nothing in the statute requires that a kickback be made of funds to which the payor would not be entitled. Payment of a kickback to those in control of federal funds is all that is required, and such payment meets the Zacher definition of corrupt payment as one "in violation of the duty imposed by Congress on providers of services to use federal funds only for intended purposes and only in the approved manner." Returning and receiving a portion of federal funds "for the opportunity to provide drugs and pharmaceutical services" is not a use of federal funds in an approved manner.

Appellants then say the Hancock indictments contained more detailed allegations of corrupt payments. The present indictments, however, alleged that payments were...